Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.22
+0.03 (0.23%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Cross Country Healthcare stock have an average target of 12.44, with a low estimate of 10 and a high estimate of 13.25. The average target predicts a decrease of -5.90% from the current stock price of 13.22.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 2 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 1 | 0 |
| Hold | 7 | 8 | 6 | 5 | 8 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Hold Maintains $13 | Hold | Maintains | $13 | +0.23% | Jun 8, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $10 → $13 | Hold | Reiterates | $10 → $13 | +0.23% | May 11, 2026 |
| Benchmark Co. | Benchmark Co. | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Citizens JMP | Citizens JMP | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 7, 2026 |
| Wedbush | Wedbush | Hold Maintains $13 | Hold | Maintains | $13 | +0.23% | May 7, 2026 |
Financial Forecast
Revenue This Year
984.15M
from 1.05B
Decreased by -6.65%
Revenue Next Year
1.02B
from 984.15M
Increased by 4.07%
EPS This Year
0.09
from 0.02
Increased by 371.45%
EPS Next Year
0.28
from 0.09
Increased by 196.96%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | 1.1B | |
| Avg | 984.1M | 1.0B | |
| Low | 968.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.1% | 10.2% | |
| Avg | -6.7% | 4.1% | |
| Low | -8.2% | 1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.15 | 0.35 | |
| Avg | 0.09 | 0.28 | |
| Low | 0.03 | 0.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 650.0% | 271.2% | |
| Avg | 371.5% | 197.0% | |
| Low | 50.0% | 122.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.